Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer.
Drooger, Jan C
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer. [electronic resource] - Breast cancer research and treatment Apr 2016 - 557-566 p. digital
Publication Type: Journal Article
1573-7217
10.1007/s10549-016-3777-0 doi
Adult
Aged
Anthracyclines--administration & dosage
BRCA1 Protein--genetics
BRCA2 Protein--genetics
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant--adverse effects
Chemotherapy-Induced Febrile Neutropenia--epidemiology
Dose-Response Relationship, Drug
Female
Germ-Line Mutation
Humans
Linear Models
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Retrospective Studies
Taxoids--administration & dosage
Young Adult
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer. [electronic resource] - Breast cancer research and treatment Apr 2016 - 557-566 p. digital
Publication Type: Journal Article
1573-7217
10.1007/s10549-016-3777-0 doi
Adult
Aged
Anthracyclines--administration & dosage
BRCA1 Protein--genetics
BRCA2 Protein--genetics
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant--adverse effects
Chemotherapy-Induced Febrile Neutropenia--epidemiology
Dose-Response Relationship, Drug
Female
Germ-Line Mutation
Humans
Linear Models
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Retrospective Studies
Taxoids--administration & dosage
Young Adult